Concepedia

Publication | Open Access

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours

DOIFull Paper Access

338

Citations

15

References

2005

Year

Ahmad Awada, Alain Hendlisz, Thierry Gil, S. Bartholomeus, Max S. Mano, Dominique de Valeriola, Dirk Strumberg, E. Brendel, Catherine G. Haase, Brian Schwartz,
British Journal of Cancer

References

YearCitations

Page 1